Cargando…
Efficacy and safety of dienogest in patients with endometriosis: A single-center observational study over 12 months
OBJECTIVE: To evaluate the efficacy and safety of dienogest treatment in patients who had received dienogest for 12 months or more to treat endometriosis. METHODS: We analyzed the clinical data of 188 women with endometriosis who had been treated with 2 mg of dienogest once a day for 12 months or mo...
Autores principales: | Park, So Yun, Kim, Sung Hoon, Chae, Hee Dong, Kim, Chung-Hoon, Kang, Byung Moon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Reproductive Medicine
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234284/ https://www.ncbi.nlm.nih.gov/pubmed/28090460 http://dx.doi.org/10.5653/cerm.2016.43.4.215 |
Ejemplares similares
-
Dienogest and the Risk of Reoperation in Endometriosis
por: Seo, Yong-Soo, et al.
Publicado: (2021) -
Study of dienogest for dysmenorrhea and pelvic pain associated with endometriosis
por: Kim, Soo Ah, et al.
Publicado: (2016) -
Quality of life and clinical factors in women with endometriosis, the role of dienogest vs EE/dienogest over time: a single-center study
por: Maiorana, Antonio, et al.
Publicado: (2023) -
Update on the treatment of endometriosis
por: Kim, Sung Hoon, et al.
Publicado: (2013) -
Dienogest in long-term treatment of endometriosis
por: Schindler, Adolf E
Publicado: (2011)